During the last three months, 17 analysts shared their evaluations of Boston Scientific (NYSE:BSX), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 9 | 6 | 2 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 3 | 2 | 1 | 0 | 0 |
2M Ago | 2 | 1 | 0 | 0 | 0 |
3M Ago | 3 | 3 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Boston Scientific, presenting an average target of $90.47, a high estimate of $100.00, and a low estimate of $78.00. This upward trend is apparent, with the current average reflecting a 6.88% increase from the previous average price target of $84.65.